
Christopher W. Fulton
Examiner (ID: 16699, Phone: (571)272-2242 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2859, 3641, 2406, 2899, 2841, 2855, 3108, 2856 |
| Total Applications | 3373 |
| Issued Applications | 2875 |
| Pending Applications | 85 |
| Abandoned Applications | 419 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5069031
[patent_doc_number] => 20070190132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Pharmaceutical compositions for oral and topical administration'
[patent_app_type] => utility
[patent_app_number] => 11/786846
[patent_app_country] => US
[patent_app_date] => 2007-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6872
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20070190132.pdf
[firstpage_image] =>[orig_patent_app_number] => 11786846
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/786846 | Pharmaceutical compositions for oral and topical administration | Apr 12, 2007 | Abandoned |
Array
(
[id] => 8807983
[patent_doc_number] => 08445635
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-21
[patent_title] => 'Modified H2 relaxin for tumor suppression'
[patent_app_type] => utility
[patent_app_number] => 12/664824
[patent_app_country] => US
[patent_app_date] => 2007-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17137
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12664824
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/664824 | Modified H2 relaxin for tumor suppression | Apr 10, 2007 | Issued |
Array
(
[id] => 299992
[patent_doc_number] => 07538193
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-26
[patent_title] => 'NO-modified hemoglobins and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/784780
[patent_app_country] => US
[patent_app_date] => 2007-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 62
[patent_no_of_words] => 32589
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/538/07538193.pdf
[firstpage_image] =>[orig_patent_app_number] => 11784780
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/784780 | NO-modified hemoglobins and uses therefor | Apr 8, 2007 | Issued |
Array
(
[id] => 4720319
[patent_doc_number] => 20080242842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Decolorization/deodorization of corn zein products'
[patent_app_type] => utility
[patent_app_number] => 11/728700
[patent_app_country] => US
[patent_app_date] => 2007-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3566
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20080242842.pdf
[firstpage_image] =>[orig_patent_app_number] => 11728700
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/728700 | Decolorization/deodorization of corn zein products | Mar 26, 2007 | Issued |
Array
(
[id] => 5070161
[patent_doc_number] => 20070191263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Valency platform molecules comprising aminooxy groups'
[patent_app_type] => utility
[patent_app_number] => 11/728853
[patent_app_country] => US
[patent_app_date] => 2007-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 25559
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191263.pdf
[firstpage_image] =>[orig_patent_app_number] => 11728853
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/728853 | Valency platform molecules comprising aminooxy groups | Mar 25, 2007 | Abandoned |
Array
(
[id] => 6008090
[patent_doc_number] => 20110060121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'METHOD OF PREPARING GLYCOPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/293793
[patent_app_country] => US
[patent_app_date] => 2007-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23225
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20110060121.pdf
[firstpage_image] =>[orig_patent_app_number] => 12293793
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/293793 | Method of preparing glycopeptides | Mar 21, 2007 | Issued |
Array
(
[id] => 9059894
[patent_doc_number] => 08546329
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-01
[patent_title] => 'Erythropoietin solution preparation'
[patent_app_type] => utility
[patent_app_number] => 12/293493
[patent_app_country] => US
[patent_app_date] => 2007-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7770
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12293493
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/293493 | Erythropoietin solution preparation | Mar 21, 2007 | Issued |
Array
(
[id] => 4734578
[patent_doc_number] => 20080051558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'Method of preparing bivalirudin'
[patent_app_type] => utility
[patent_app_number] => 11/716124
[patent_app_country] => US
[patent_app_date] => 2007-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9270
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20080051558.pdf
[firstpage_image] =>[orig_patent_app_number] => 11716124
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/716124 | Method of preparing bivalirudin | Mar 8, 2007 | Abandoned |
Array
(
[id] => 6280780
[patent_doc_number] => 20100119588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'PEPTIDE FOR INHIBITION OF INFLUENZA INFECTION, INHIBITOR OF INFLUENZA INFECTION, LIPOSOME, AND PROPHYLACTIC/THERAPEUTIC AGENT FOR INFLUENZA'
[patent_app_type] => utility
[patent_app_number] => 12/282807
[patent_app_country] => US
[patent_app_date] => 2007-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11380
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20100119588.pdf
[firstpage_image] =>[orig_patent_app_number] => 12282807
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/282807 | Influenza infection-inhibiting peptide, influenza virus infection inhibitor, liposome, and influenza preventive/therapeutic agent | Mar 6, 2007 | Issued |
Array
(
[id] => 7691484
[patent_doc_number] => 20070232549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Novel peptides as NS3-serine protease inhibitors of hepatitis C virus'
[patent_app_type] => utility
[patent_app_number] => 11/714457
[patent_app_country] => US
[patent_app_date] => 2007-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45259
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20070232549.pdf
[firstpage_image] =>[orig_patent_app_number] => 11714457
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/714457 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Mar 5, 2007 | Issued |
Array
(
[id] => 5480669
[patent_doc_number] => 20090203626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Pediatric Amino Acid Solution for Parenteral Nutrition'
[patent_app_type] => utility
[patent_app_number] => 12/226358
[patent_app_country] => US
[patent_app_date] => 2007-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4502
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203626.pdf
[firstpage_image] =>[orig_patent_app_number] => 12226358
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/226358 | Pediatric amino acid solution for parenteral nutrition | Mar 4, 2007 | Issued |
Array
(
[id] => 10649387
[patent_doc_number] => 09365622
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-14
[patent_title] => 'Methods and compositions related to cyclic peptide synthesis'
[patent_app_type] => utility
[patent_app_number] => 12/281373
[patent_app_country] => US
[patent_app_date] => 2007-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 49
[patent_no_of_words] => 38256
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12281373
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/281373 | Methods and compositions related to cyclic peptide synthesis | Feb 28, 2007 | Issued |
Array
(
[id] => 8017287
[patent_doc_number] => 08138146
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-20
[patent_title] => 'Antiviral peptide and antiviral agent'
[patent_app_type] => utility
[patent_app_number] => 12/280701
[patent_app_country] => US
[patent_app_date] => 2007-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9930
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 251
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/138/08138146.pdf
[firstpage_image] =>[orig_patent_app_number] => 12280701
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/280701 | Antiviral peptide and antiviral agent | Feb 27, 2007 | Issued |
Array
(
[id] => 5987693
[patent_doc_number] => 20110098442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'PEPTIDES AND PEPTIDE DERIVATIVES AS WELL AS PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/280543
[patent_app_country] => US
[patent_app_date] => 2007-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7885
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098442.pdf
[firstpage_image] =>[orig_patent_app_number] => 12280543
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/280543 | PEPTIDES AND PEPTIDE DERIVATIVES AS WELL AS PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | Feb 22, 2007 | Abandoned |
Array
(
[id] => 5120587
[patent_doc_number] => 20070142302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'PEPTIDYL PRODRUGS THAT RESIST P-GLYCOPROTEIN MEDIATED DRUG EFFLUX'
[patent_app_type] => utility
[patent_app_number] => 11/677947
[patent_app_country] => US
[patent_app_date] => 2007-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14659
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142302.pdf
[firstpage_image] =>[orig_patent_app_number] => 11677947
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/677947 | Peptidyl prodrugs that resist P-glycoprotein mediated drug efflux | Feb 21, 2007 | Issued |
Array
(
[id] => 5452699
[patent_doc_number] => 20090068736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'Mutant proline-and-arginine rich peptides and methods for using the same'
[patent_app_type] => utility
[patent_app_number] => 11/673790
[patent_app_country] => US
[patent_app_date] => 2007-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11660
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20090068736.pdf
[firstpage_image] =>[orig_patent_app_number] => 11673790
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/673790 | Mutant proline-and-arginine rich peptides and methods for using the same | Feb 11, 2007 | Issued |
Array
(
[id] => 53691
[patent_doc_number] => 07772427
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-10
[patent_title] => 'Uses for amino acid anticonvulsants'
[patent_app_type] => utility
[patent_app_number] => 11/651845
[patent_app_country] => US
[patent_app_date] => 2007-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14812
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/772/07772427.pdf
[firstpage_image] =>[orig_patent_app_number] => 11651845
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/651845 | Uses for amino acid anticonvulsants | Jan 9, 2007 | Issued |
| 61/196711 | GLP-1 pharmaceutical compositions | Dec 28, 2006 | Pending |
Array
(
[id] => 44497
[patent_doc_number] => 07777030
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-17
[patent_title] => 'Compositions and methods for the treatment and prevention of disease'
[patent_app_type] => utility
[patent_app_number] => 11/644626
[patent_app_country] => US
[patent_app_date] => 2006-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10222
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/777/07777030.pdf
[firstpage_image] =>[orig_patent_app_number] => 11644626
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/644626 | Compositions and methods for the treatment and prevention of disease | Dec 21, 2006 | Issued |
Array
(
[id] => 4960714
[patent_doc_number] => 20080275139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Cyclodextrin-Containing Polymers and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/158091
[patent_app_country] => US
[patent_app_date] => 2006-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17260
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20080275139.pdf
[firstpage_image] =>[orig_patent_app_number] => 12158091
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/158091 | Cyclodextrin-Containing Polymers and Uses Thereof | Dec 18, 2006 | Abandoned |